<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00882817</url>
  </required_header>
  <id_info>
    <org_study_id>B32220095560</org_study_id>
    <secondary_id>S1490</secondary_id>
    <nct_id>NCT00882817</nct_id>
  </id_info>
  <brief_title>Pulmonary Rehabilitation in Interstitial Lung Diseases</brief_title>
  <official_title>Effects of Pulmonary Rehabilitation in Interstitial Lung Diseases: a Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment in interstitial lung diseases (ILD) is frequently ineffective. Pulmonary
      rehabilitation (PR) is an excellent therapeutic option in another chronic lung diseases such
      as chronic obstructive pulmonary disease (COPD). This prospective randomized controlled study
      aims to evaluate the short and long-term effects of PR in patients with ILD. For this
      purpose, 60 ILD patients will be randomly assigned to a PR or a control group.

      The investigators hypothesize that PR will improve exercise capacity, increase muscle force,
      reduce dyspnea and improve quality of life and daily life activities in ILD patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in six minute walking distance after 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>primary outcome of rehabilitation programm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in dyspnea and quality of life scores (MMRC, CRDQ, SGRQ),</measure>
    <time_frame>3-6-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in peripheral and respiratory muscle force</measure>
    <time_frame>3-6-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in maximal exercise capacity</measure>
    <time_frame>3-6-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in daily physical activity measured by Sensewear armband</measure>
    <time_frame>3-6-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in pulmonary function and blood gases at rest</measure>
    <time_frame>3-6-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change number of disease-related hospitalizations and survival</measure>
    <time_frame>3-6-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in functional exercise capacity measured by the 6 minute walking distance</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate feasibility and safety of pulmonary rehabilitation in interstitial lung disease</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in six minute walking distance</measure>
    <time_frame>at 3, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Interstitial Lung Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulmonary Rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulmonary Rehabilitation</intervention_name>
    <description>The intervention group will perform a 6 month pulmonary rehabilitation program which consists of training, patient education, nutrition counseling and psychosocial support. They will be evaluated with some tests for the study.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of interstitial lung disease according to internationally established
             criteria

          -  Dyspnea on exertion

          -  Stable medical therapy

          -  Stable clinical condition at inclusion, with no infection or exacerbation in the
             previous 4 weeks

        Exclusion Criteria:

          -  Co-morbidities that do not allow exercise training (unstable angina, recent myocardial
             infarction or cerebrovascular accident, active cancer, severe orthopedic disorders).

          -  Life expectancy below 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia PÃ©rez-Bogerd, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wim Janssens, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wim Wuyts, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Katholieke Universiteit Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Flanders</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2009</study_first_submitted>
  <study_first_submitted_qc>April 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2009</study_first_posted>
  <last_update_submitted>July 31, 2013</last_update_submitted>
  <last_update_submitted_qc>July 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Marc Decramer</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>ILD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

